J G Cairncross1. Show Affiliations » 1. Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.
Abstract
Entities: Disease
Mesh: See more » Alkylating Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useBrain Neoplasms/drug therapyBrain Neoplasms/surgeryChemotherapy, AdjuvantCisplatin/administration & dosageClinical Trials, Phase II as TopicCombined Modality TherapyCyclophosphamide/administration & dosageGlioma/drug therapyHumansLomustine/administration & dosageMulticenter Studies as TopicNeoplasm Recurrence, Local/drug therapyOligodendroglioma/drug therapyOligodendroglioma/surgeryProcarbazine/administration & dosageSalvage TherapyVincristine/administration & dosageVindesine/administration & dosage
Substances: See more » Alkylating AgentsProcarbazineVincristineLomustineCyclophosphamideCisplatinVindesine
Year: 1994 PMID: 8047688 DOI: 10.1007/978-3-642-85039-4_13
Source DB: PubMed Journal: Recent Results Cancer Res ISSN: 0080-0015